ACHV
Achieve Life Sciences Inc.

15,988
Loading...
Loading...
News
all
press releases
Achieve Life Sciences: Strong Buy Rating on ORCA-OL Trial Progress and FDA Breakthrough Designation
JonesTrading analyst Justin Walsh has reiterated their bullish stance on ACHV stock, giving a Buy rating today. Justin Walsh has given his Buy rati...
TipRanks Financial Blog·1y ago
News Placeholder
More News
News Placeholder
Achieve Life Sciences (NASDAQ:ACHV) Given Outperform Rating at Oppenheimer
Oppenheimer restated their outperform rating on shares of Achieve Life Sciences (NASDAQ:ACHV - Free Report) in a research report sent to investors on Monday morning, Benzinga reports. They currently...
Zolmax·1y ago
News Placeholder
Achieve Life Sciences (ACHV, $4.58) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024
This indicator may be signaling that ACHV's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Stocks·1y ago
News Placeholder
Q4 2023 Achieve Life Sciences Inc Earnings Call Transcript
Related Stocks: NAS:ACHV...
GuruFocus·1y ago
News Placeholder
Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript
Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript...
SeekingAlpha·1y ago
News Placeholder
Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript
Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript...
Seeking Alpha: Transcripts·1y ago
News Placeholder
ACHV Stock Earnings: Achieve Life Sciences Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ACHV stock results show that Achieve Life Sciences beat analyst estimates for earnings per share the fourth quarter of 2023. The post...
InvestorPlace·1y ago
News Placeholder
Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval
ACHV Aligns with EPS Projections, Focuses on Cytisinicline DevelopmentRelated Stocks: ACHV...
GuruFocus·1y ago
News Placeholder
Achieve Life Sciences reports Q4 EPS (26c), consensus (31c)
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
Company to host conference call at 4:30 PM EDT today, Thursday, March 28, 2024SEATTLE and VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV...
Globe Newswire·1y ago

Latest ACHV News

View

Advertisement. Remove ads.

Advertisement. Remove ads.